With Nicola Cotugno Why are you involved in the EPIICAL project and what’s your role? I became interested in HIV-related immunology after receiving my degree in Medicine and when, as…
by Alfredo Tagarro Between the 1st and 16th February 2018, a team of researchers from the EPIICAL platform carried out site visits for the EARTH study. The team was composed…
by Avy Violari In 2018, nearly 2 years after starting protocol development, the EARTH study enrolled its first participant in Soweto, South Africa. The study enrolled infants who tested HIV positive…
Lynne M. Mofenson is a key member of the Independent Scientific Advisory Board, and provides external consultancy for EPIICAL. She is a pediatric infectious disease specialist who has spent her…
The annual Conference on Retroviruses and Opportunistic Infections (CROI) was held on 4-7 March 2019, at the Washington State Convention Center in Seattle, Washington.
Seattle is gearing up for the 2019 edition of CROI next week. Held at Washington State Convention Center on 4th-7th March, the Conference on Retroviruses and Opportunistic Infections is an important event…
10 Dec, 2018
SAVE THE DATE: Next General Assembly in Cape Town, 20-22 November 2019
29 Nov, 2018
World AIDS Day December 1st - What this means to EPIICAL
Born from the collaboration among EPPICC and EPIICAL, the paper “Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand” demonstrates that even amongst HIV infected…
Held at the Hospital General Universitario Gregorio Marañón on 14th to 16th November 2018, the 2nd EPIICAL General Assembly welcomed around 50 scientists and healthcare professionals working together to establish…